CMS defends proposal to nix MCIT pathway, medtechs hold out hope
Among the top issues generating buzz at this week’s AdvaMed conference was the decision by CMS earlier this month to propose killing off the Medicare Coverage of Innovative Technology pathway for breakthrough devices due to clinical evidence concerns. AdvaMed has protested the proposed CMS repeal, remains disappointed but contends there is still hope for a potential compromise. At… Read More »
